These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Orbital implants of coralline hydroxyapatite as eye replacement after enucleation]. Busin M; Mönks T; Menzel C Klin Monbl Augenheilkd; 1994 Jun; 204(6):518-22. PubMed ID: 7933898 [TBL] [Abstract][Full Text] [Related]
8. Influence of coralline hydroxyapatite used as an ocular implant on the dose distribution of external beam photon radiation therapy. Arora V; Weeks K; Halperin EC; Dutton JJ Ophthalmology; 1992 Mar; 99(3):380-2. PubMed ID: 1314363 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of vascularization of coralline hydroxyapatite ocular implants by magnetic resonance imaging. Hamilton HE; Christianson MD; Williams JP; Thomas RA Clin Imaging; 1992; 16(4):243-6. PubMed ID: 1335353 [TBL] [Abstract][Full Text] [Related]
10. Vascularization of coralline versus synthetic hydroxyapatite orbital implants assessed by gadolinium enhanced magnetic resonance imaging. Celik T; Yuksel D; Kosker M; Kasim R; Simsek S Curr Eye Res; 2015 Mar; 40(3):346-53. PubMed ID: 24871378 [TBL] [Abstract][Full Text] [Related]
11. Hydroxyapatite orbital implants. Scanning with technetium-99m MDP. Numerow LM; Kloiber R; Mitchell RJ; Molnar CP; Anderson MA Clin Nucl Med; 1994 Jan; 19(1):9-12. PubMed ID: 7511087 [TBL] [Abstract][Full Text] [Related]
12. Effect of sucralfate and basic fibroblast growth factor on fibrovascular ingrowth into hydroxyapatite and porous polyethylene alloplastic implants using a novel rabbit model. Rubin PA; Nicaeus TE; Warner MA; Remulla HD Ophthalmic Plast Reconstr Surg; 1997 Mar; 13(1):8-17. PubMed ID: 9076777 [TBL] [Abstract][Full Text] [Related]
13. Gadolinium-enhanced magnetic resonance imaging assessment of hydroxyapatite orbital implants. Spirnak JP; Nieves N; Hollsten DA; White WC; Betz TA Am J Ophthalmol; 1995 Apr; 119(4):431-40. PubMed ID: 7535979 [TBL] [Abstract][Full Text] [Related]
16. [A study of living response to artificially synthesized hydroxyapatite implant in the rabbit orbit]. Saitoh A; Tsuda Y; Bhutto IA; Kitaoka T; Amemiya T Nippon Ganka Gakkai Zasshi; 1995 Apr; 99(4):420-6. PubMed ID: 7741054 [TBL] [Abstract][Full Text] [Related]
17. Management of exposed hydroxyapatite orbital implants. Kim YD; Goldberg RA; Shorr N; Steinsapir KD Ophthalmology; 1994 Oct; 101(10):1709-15. PubMed ID: 7936570 [TBL] [Abstract][Full Text] [Related]
18. Long-term bone ingrowth and residual microhardness of porous block hydroxyapatite implants in humans. Ayers RA; Simske SJ; Nunes CR; Wolford LM J Oral Maxillofac Surg; 1998 Nov; 56(11):1297-301; discussion 1302. PubMed ID: 9820218 [TBL] [Abstract][Full Text] [Related]
19. Bone ingrowth and mechanical properties of coralline hydroxyapatite 1 yr after implantation. Martin RB; Chapman MW; Sharkey NA; Zissimos SL; Bay B; Shors EC Biomaterials; 1993 Apr; 14(5):341-8. PubMed ID: 8389612 [TBL] [Abstract][Full Text] [Related]
20. Exposure rate of hydroxyapatite spheres in the anophthalmic socket: histopathologic correlation and comparison with silicone sphere implants. Nunery WR; Heinz GW; Bonnin JM; Martin RT; Cepela MA Ophthalmic Plast Reconstr Surg; 1993 Jun; 9(2):96-104. PubMed ID: 8391837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]